Mouse Anti-MEAK7 Recombinant Antibody (CBYJT-1454) (CBMAB-T0485-YJ)

Wang, L., Wu, D., Robinson, C. V., & Fu, T. M. (2022). Identification of mEAK-7 as a human V-ATPase regulator via cryo-EM data mining. Proceedings of the National Academy of Sciences, 119(35), e2203742119.

Wang, R., Qin, Y., Xie, X. S., & Li, X. (2022). Molecular basis of mEAK7-mediated human V-ATPase regulation. Nature communications, 13(1), 3272.

Tan, Y. Z., Abbas, Y. M., Wu, J. Z., Wu, D., Keon, K. A., Hesketh, G. G., ... & Rubinstein, J. L. (2022). CryoEM of endogenous mammalian V-ATPase interacting with the TLDc protein mEAK-7. Life Science Alliance, 5(11).

Tan, Y. Z., Abbas, Y. M., Wu, J. Z., Wu, D., Hesketh, G. G., Bueler, S. A., ... & Rubinstein, J. L. (2021). Structure of mammalian V-ATPase with the TLDc domain protein mEAK7 bound. BioRxiv.

Mendonça, D. B., Nguyen, J. T., Haidar, F., Fox, A. L., Ray, C., Amatullah, H., ... & Krebsbach, P. H. (2020). MicroRNA-1911-3p targets mEAK-7 to suppress mTOR signaling in human lung cancer cells. Heliyon, 6(12).

Nguyen, J. T., Haidar, F. S., Fox, A. L., Ray, C., Mendonça, D. B., Kim, J. K., & Krebsbach, P. H. (2020). Abstract B05: mEAK-7 supports self-renewal and radioresistance in metastatic cancer. Molecular Cancer Research, 18(10_Supplement), B05-B05.

Nguyen, J. T., Haidar, F. S., Fox, A. L., Ray, C., Mendonça, D. B., Kim, J. K., & Krebsbach, P. H. (2019). mEAK-7 forms an alternative mTOR complex with DNA-PKcs in human cancer. Iscience, 17, 190-207.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols